
About Aliri
Aliri is committed to solving industry challenges by bringing innovative bioanalytical and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise.
Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.
Learn more about a vast range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
Learn more about a vast range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
Across our portfolio, we are committed to bringing strong customer service, scientific leadership, and regulatory excellence, which are all bound to our core values:
Action
- Deliver results and actively problem solve with speed
- Find solutions and processes to be more productive and efficient
Attentive
- Advance programs with collaboration and communication
- Create inclusive environments across projects and teams
Aspire
- Innovate to enable customers to advance their life-saving molecules
- Commit to company growth and personal development
Accountable
- Take responsibility for all actions and outcomes with integrity
- Provide superior expertise with every project
Our Leadership
Jonathan Stauber
Chief Executive Officer
Prior his position as CEO of Aliri, Jonathan founded Imabiotech, a CRO based imaging company. Carrying out several fundraising campaigns with Business Angels, seed funds and development funds, he developed the company to support various regions. Holding a PhD degree in biochemistry and an MBA from University of Lille and University of California San Diego, he worked in research laboratories in California, France and Netherlands where he published more than 30 publications in international journals and obtained several patents based on the development of molecular imaging and bioanalytical methods.
Maurice Gaubatz
Chief Business Officer
Jim Wilfahrt
Chief Operating Officer
Jim Wilfahrt, Chief Operating Officer, began his career in the Bioanalytical CRO industry in 1994 with the founding of Tandem Labs. Following the successful establishment of Tandem Labs as a Best-in-Class Bioanalytical CRO provider, Tandem Labs was acquired by Laboratory Corporation of America. Jim continued in his role as General Manager for Tandem Labs operations and LabCorp Vice President through 2016, at which time he assumed the role of Global Head, Bioanalytical for Covance. Jim joined Pyxant Labs as President in 2020 and became Chief Operating Officer in 2022.
Sylvain Chabanier
Chief Financial Officer